Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 619 clinical trials
A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

This study is being done to see if hydroxychloroquine is an effective treatment for COVID-19.

acute respiratory syndrome (sars)
hydroxychloroquine
covid-19
SARS
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients

The purpose of this study assess the efficacy and safety of anti-SARS-CoV-2 convalescent plasma in hospitalized patients with acute respiratory symptoms up to 14 days after the onset of initial symptoms.

acute respiratory syndrome (sars)
chest imaging
respiratory symptom
coronavirus infection
covid-19
  • 0 views
  • 19 Feb, 2024
  • 3 locations
Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19

The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.

acute respiratory syndrome (sars)
nasopharyngeal swab
covid-19
SARS
  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients

To measure the effect of Ivermectin (sub-cutaneous) with or without zinc and Nigella sativa in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

acute respiratory syndrome (sars)
nigella sativa / black cumin
SARS
zinc
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Nigella Sativa in COVID-19

Natural products with immunomodulation and antiviral activity showed a promising improvement in the outcomes of some viral infectious diseases both in preclinical and primitive clinical studies. The aim of this study is to utilize Saudi FDA licensed Nigella sativa (NS) seed oil towards improving disease outcomes in hospitalized adult patients …

acute respiratory syndrome (sars)
respiratory tract infection
respiratory infection
covid-19
antiviral drugs
  • 0 views
  • 19 Feb, 2024
  • 1 location
QuadraMune(TM) for Prevention of COVID-19

QuadraMune(TM) is a nutritional supplement which has previously been demonstrated to possess antiinflammatory and immune modulatory activity based on in vitro and pilot in vivo studies. The current clinical trial aims to assess in a 500 volunteer trial the efficacy of QuadraMune(TM) in reducing infection in individuals at high risk …

oral contraceptives
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy of Iodine Complex Against COVID-19 Patients

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

acute respiratory syndrome (sars)
covid-19
SARS
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Evaluate the Effect of a Probiotic in COVID-19

A prospective case-control pilot study to evaluate the possible effect of a probiotic mixture in the improvement of symptoms, the reduction in the number of days of hospitalization and the increase in the percentage of patients with negative PCR after infection with the coronavirus SARS-CoV-2.

acute respiratory syndrome (sars)
coronavirus infection
covid-19
SARS
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

This is an open label, dose escalating safety study of the advanced therapy investigational medicinal product (ATIMP) KI-MSC-PL-205, where patients diagnosed with SARS-CoV-2-induced severe acute respiratory distress syndrome (ARDS), according to the Berlin Definition, and who are on respirator/ventilator (used synonymously in this protocol) support due to respiratory insufficiency with …

acute respiratory syndrome (sars)
acute respiratory distress
respiratory distress
cell therapy
PCR test
  • 0 views
  • 19 Feb, 2024
  • 1 location
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

This is a 14-day long prospective, multi-site, two-armed, randomized, open-label study that will enroll approximately 100 adult outpatients in Canada who have received a positive SARS-CoV-2 test result within the preceding 72 hours. Participants will be randomized (1:1) to receive either icosapent ethyl (4 g BID for 3 days, then …

acute respiratory syndrome (sars)
fever
cough
sore throat
myalgia
  • 0 views
  • 19 Feb, 2024
  • 1 location